[Efficacy of ibutilide for cardioversion of persistent atrial fibrillation during radiofrequency ablation].

Zhonghua xin xue guan bing za zhi 20111101

Factors affecting the degree of QT prolongation with drug challenge in a large cohort of normal volunteers.

Heart rhythm 20111001

Predicting the degree of drug-induced QT prolongation and the risk for torsades de pointes.

Heart rhythm 20111001

Drug-induced torsade de pointes arrhythmias in the chronic AV block dog are perpetuated by focal activity.

Circulation. Arrhythmia and electrophysiology 20110801

A 2-year survey of treatment of acute atrial fibrillation in an ED.

The American journal of emergency medicine 20110601

Effects of ibutilide on inhibiting heart rate and rapidly terminating atrial flutter in canine.

Cell biochemistry and biophysics 20110401

Atrial fibrillation: AVRO--were the results a surprise?

Nature reviews. Cardiology 20110401

Single dose of ibutilide for conversion of persistent atrial fibrillation after radiofrequency ablation.

Chinese medical journal 20110301

Safety and efficacy of ibutilide in cardioversion of atrial flutter and fibrillation.

Journal of the American Board of Family Medicine : JABFM 20110101

Effect of high doses of magnesium on converting ibutilide to a safe and more effective agent.

The American journal of cardiology 20100901

Pre-injection of magnesium sulfate enhances the efficacy of ibutilide for the conversion of typical but not of atypical persistent atrial flutter.

International journal of cardiology 20100611

Intraprocedural use of ibutilide to organize and guide ablation of complex fractionated atrial electrograms: preliminary assessment of a modified step-wise approach to ablation of persistent atrial fibrillation.

Journal of cardiovascular electrophysiology 20100601

2:1 left to right interatrial block and other effects of ibutilide during non-isthmus-dependent atrial flutter.

Pacing and clinical electrophysiology : PACE 20091001

[The study of inhibiting heart rate and rapidly terminating atrial flutter of ibutilide on canine].

Zhonghua xin xue guan bing za zhi 20091001

Ibutilide-induced changes in the temporal lability of ventricular repolarization in patients with and without structural heart disease.

Journal of cardiovascular electrophysiology 20090801

The organic cation transporter, OCTN1, expressed in the human heart, potentiates antagonism of the HERG potassium channel.

Journal of cardiovascular pharmacology 20090701

Influence of the G2677T/C3435T haplotype of MDR1 on P-glycoprotein trafficking and ibutilide-induced block of HERG.

The pharmacogenomics journal 20090601

Safety and efficacy of ibutilide in heart transplant recipients.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 20090501

Acute beta-adrenoceptor blockade improves efficacy of ibutilide in conversion of atrial fibrillation with a rapid ventricular rate.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 20090101

Ibutilide revisited: stronger and safer than ever.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 20090101

Pharmacokinetics of ibutilide in patients with heart failure due to left ventricular systolic dysfunction.

Pharmacotherapy 20081201

Extracellular acidification and hyperkalemia induce changes in HERG inhibition by ibutilide.

Cardiology 20080101

Rapid ventricular response.

American journal of critical care : an official publication, American Association of Critical-Care Nurses 20080101

Ibutilide therapy for atrial fibrillation: 5-year experience in a community hospital.

The Journal of cardiovascular nursing 20080101

Intravenous magnesium sulfate enhances the ability of intravenous ibutilide to successfully convert atrial fibrillation or flutter.

Pacing and clinical electrophysiology : PACE 20071101

Autonomic tone attenuates drug-induced QT prolongation.

Journal of cardiovascular electrophysiology 20070901

Monotherapy versus combination therapy with class III antiarrhythmic agents to attenuate transmural dispersion of repolarization: a potential risk factor for torsade de pointes.

Pharmacotherapy 20070901

Pharmacokinetic and pharmacodynamic properties of a single intravenous dose of ibutilide fumarate: a phase I, randomized, open-label, increasing-dose study in healthy Chinese men.

Clinical therapeutics 20070901

The safety and efficacy of ibutilide in children and in patients with congenital heart disease.

Pacing and clinical electrophysiology : PACE 20070801

Enhancement of bupivacaine local anesthesia with the potassium channel blocker ibutilide.

European journal of pain (London, England) 20070701

Cardioversion of persistent atrial fibrillation by a combination of atrial specific and non-specific class III drugs in the goat.

Cardiovascular research 20070701

Conversion efficacy of intravenous ibutilide compared with intravenous amiodarone in patients with recent-onset atrial fibrillation and atrial flutter.

International journal of cardiology 20070612

Ibutilide and sinus arrest.

Herz 20070601

Ibutilide-induced cardioversion of atrial fibrillation during pregnancy.

Journal of cardiovascular electrophysiology 20070501

Successful termination of atrial flutter by ibutilide during pregnancy.

Pacing and clinical electrophysiology : PACE 20070201

The role of amiodarone in recent-onset atrial fibrillation after ibutilide has failed to restore sinus rhythm.

Cardiology 20070101

The mechanisms of atrial fibrillation.

Journal of cardiovascular electrophysiology 20061201

Bazett and Fridericia QT correction formulas interfere with measurement of drug-induced changes in QT interval.

Heart rhythm 20060901

Ibutilide to expedite ED therapy for recent-onset atrial fibrillation flutter.

The American journal of emergency medicine 20060701

Propafenone added to ibutilide increases conversion rates of persistent atrial fibrillation.

Heart (British Cardiac Society) 20060501

Efficacy and safety of ibutilide for the conversion of monomorphic atrial tachycardia.

Pacing and clinical electrophysiology : PACE 20060401

Drug binding interactions in the inner cavity of HERG channels: molecular insights from structure-activity relationships of clofilium and ibutilide analogs.

Molecular pharmacology 20060201

Ibutilide for treatment of atrial fibrillation in the emergency department.

Emergency medicine journal : EMJ 20060201

Is pretreatment with ibutilide useful for atrial fibrillation cardioversion when combined with biphasic shock?

Journal of cardiovascular medicine (Hagerstown, Md.) 20060201

High-density mapping of pulmonary veins and left atrium during ibutilide administration in a canine model of sustained atrial fibrillation.

American journal of physiology. Heart and circulatory physiology 20051201

In vivo antiarrhythmic and cardiac electrophysiologic effects of a novel diphenylphosphine oxide IKur blocker (2-isopropyl-5-methylcyclohexyl) diphenylphosphine oxide.

The Journal of pharmacology and experimental therapeutics 20051201

Comparison of intravenous ibutilide vs. propafenone for rapid termination of recent onset atrial fibrillation.

International journal of clinical practice 20051201

[Inhibition of the muscarinic potassium current by KB130015, a new antiarrhythmic agent to treat atrial fibrillation].

Medizinische Klinik (Munich, Germany : 1983) 20051115

[Atrial flutter and fibrillation].

Praxis 20051109

Synthesis of biologically active amines via rhodium-bisphosphite-catalyzed hydroaminomethylation.

Organic letters 20051027

Efficacy and safety of ibutilide for cardioversion of atrial flutter and fibrillation in patients receiving amiodarone or propafenone.

Pacing and clinical electrophysiology : PACE 20050901

Rapid cardioversion of new onset atrial fibrillation with ibutilide in the emergency department.

Irish medical journal 20050901

The combined use of ibutilide as an active control with intensive electrocardiographic sampling and signal averaging as a sensitive method to assess the effects of tadalafil on the human QT interval.

Journal of the American College of Cardiology 20050816

Making a silk purse out of a sow's ear.

Journal of the American College of Cardiology 20050816

Consequences of atrial electrical remodeling for the anti-arrhythmic action of class IC and class III drugs.

Cardiovascular research 20050701

Conversion of recent-onset atrial fibrillation or flutter with amiodarone after ibutilide has failed: a rapid, efficient, and safe algorithm.

Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc 20050701

Ibutilide--recent molecular insights and accumulating evidence for use in atrial flutter and fibrillation.

Expert opinion on investigational drugs 20050501

[Immediate cardioversion of atrial fibrillation and atrial flutter lasting less than 90 days by ibutilide versus propafenone: a multicenter study].

Zhonghua yi xue za zhi 20050330

Ibutilide in persistent atrial fibrillation refractory to conventional cardioversion methods.

International journal of cardiology 20050318

Sensitive method for the determination of ibutilide in human plasma by liquid chromatography-tandem mass spectrometry.

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20050225

Ibutilide for rapid conversion of atrial fibrillation or flutter in a mixed critically ill patient population.

Wiener klinische Wochenschrift 20050201

Comparative efficacy of monophasic and biphasic waveforms for transthoracic cardioversion of atrial fibrillation and atrial flutter.

American heart journal 20050201

Clinical comparison of ibutilide and propafenone for converting atrial flutter.

Cardiovascular drugs and therapy 20050101

A benefit-risk assessment of class III antiarrhythmic agents.

Expert opinion on drug safety 20041101

Ibutilide (Corvert): suspected association with torsades de pointes.

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20041012

Electrophysiological and proarrhythmic parameters in transmural canine left-ventricular needle biopsies.

Pflugers Archiv : European journal of physiology 20041001

'Early' class III drugs for the treatment of atrial fibrillation: efficacy and atrial selectivity of AVE0118 in remodeled atria of the goat.

Circulation 20040928

Ibutilide added to propafenone for the conversion of atrial fibrillation and atrial flutter.

Journal of the American College of Cardiology 20040818

Use of ibutilide in cardioversion of patients with atrial fibrillation or atrial flutter treated with class IC agents.

Journal of the American College of Cardiology 20040818

Structural determinants of HERG channel block by clofilium and ibutilide.

Molecular pharmacology 20040801

Pharmacological cardioversion of recent onset atrial fibrillation.

European heart journal 20040801

Flecainide versus ibutilide for immediate cardioversion of atrial fibrillation of recent onset.

European heart journal 20040801

[Perspectives and limitations in the treatment of vagus-induced atrial fibrillation. Insights from cellular pharmacology].

Medizinische Klinik (Munich, Germany : 1983) 20040715

Efficacy and safety of ibutilide vs. transoesophageal atrial pacing for the termination of type I atrial flutter.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 20040701

Atrial-selective antiarrhythmic actions of novel Ikur vs. Ikr, Iks, and IKAch class Ic drugs and beta blockers in pigs.

Medical science monitor : international medical journal of experimental and clinical research 20040701

Intrapericardial ibutilide administration fails to terminate pacing-induced sustained atrial fibrillation in dogs.

Cardiovascular drugs and therapy 20040701

Facilitating internal cardioversion of chronic atrial fibrillation with ibutilide--predictors of atrial defibrillation-threshold decrease.

Medical science monitor : international medical journal of experimental and clinical research 20040601

Female preponderance in ibutilide-induced torsade de pointes.

International journal of cardiology 20040601

Ibutilide-induced alterations in electrocardiographic and spatial vectorcardiographic descriptors of ventricular repolarization.

Clinical cardiology 20040601

Comparing methods of measurement for detecting drug-induced changes in the QT interval: implications for thoroughly conducted ECG studies.

Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc 20040401

Model of effect of magnesium prophylaxis on frequency of torsades de pointes in ibutilide-treated patients.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20040401

Ibutilide for cardioversion of atrial flutter: efficacy of a single dose in recent-onset arrhythmias.

Minerva cardioangiologica 20040201

Oral class III antiarrhythmics: what is new?

Current opinion in cardiology 20040101

Use of ibutilide for cardioversion of recent-onset atrial fibrillation and flutter in elderly.

American journal of therapeutics 20040101

Genetic basis of drug-induced arrhythmias.

Annals of medicine 20040101

Recent developments in cardiovascular drug therapy: treatment of atrial arrhythmias with new class III drugs and beyond.

Current medicinal chemistry. Cardiovascular and hematological agents 20040101

Cost effectiveness of ibutilide with prophylactic magnesium in the treatment of atrial fibrillation.

PharmacoEconomics 20040101

Adjunctive intravenous magnesium to reduce toxicity and enhance efficacy of class III antiarrhythmic agents.

Connecticut medicine 20040101

Impact of prophylactic i.v. magnesium on the efficacy of ibutilide for conversion of atrial fibrillation or flutter.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20031115

[Progress in the clinical use of anti-arrhythmic drugs (I)].

Zhonghua er ke za zhi = Chinese journal of pediatrics 20031001

An update on electrical cardioversion of atrial fibrillation.

Cardiac electrophysiology review 20030901

Effectiveness of ibutilide in cardioversion of persistent atrial fibrillation in patients with dual chamber stimulation.

Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing 20030801

Ibutilide versus amiodarone in atrial fibrillation: a double-blinded, randomized study.

Critical care medicine 20030401

Pharmacologic and nonpharmacologic options to maintain sinus rhythm: guideline-based and new approaches.

The American journal of cardiology 20030320

Effects of intravenous magnesium sulfate on the QT interval in patients receiving ibutilide.

Pharmacotherapy 20030301

Propafenone versus ibutilide for post operative atrial fibrillation following cardiac surgery: neither strategy improves outcomes compared to rate control alone (the PIPAF study).

Medical science monitor : international medical journal of experimental and clinical research 20030301

Atrial fibrillation in the elderly.

The American journal of geriatric cardiology 20030101

Potentially significant drug interactions of class III antiarrhythmic drugs.

Drug safety 20030101

Ibutilide for pharmacological cardioversion of atrial fibrillation and flutter: impact of race on efficacy and safety.

American journal of therapeutics 20030101

[Development of original Russian antiarrhythmic drugs of the 3rd class].

Vestnik Rossiiskoi akademii meditsinskikh nauk 20030101

Electrophysiological and antiarrhythmic effects of the novel I(Kur) channel blockers, S9947 and S20951, on left vs. right pig atrium in vivo in comparison with the I(Kr) blockers dofetilide, azimilide, d,l-sotalol and ibutilide.

Naunyn-Schmiedeberg's archives of pharmacology 20021101

Hybrid therapy of atrial fibrillation.

Italian heart journal : official journal of the Italian Federation of Cardiology 20021001

Comparison of amiodarone versus ibutilide for the prevention of immediate recurrences of atrial fibrillation during pulmonary vein isolation.

The American journal of cardiology 20020901

Cardioversion of atrial fibrillation with ibutilide: when is it most effective?

Clinical cardiology 20020901

Electrophysiological response of the right atrium to ibutilide during typical atrial flutter.

Circulation 20020813

Conversion of recent-onset atrial fibrillation or flutter with ibutilide after amiodarone has failed.

Intensive care medicine 20020701

[Current strategies of pharmacological and non-pharmacological treatment in atrial fibrillation and atrial flutter].

Nihon rinsho. Japanese journal of clinical medicine 20020701

[Ventricular fibrillation/tachycardia].

Nihon rinsho. Japanese journal of clinical medicine 20020701

Comparison of verapamil and ibutilide for the suppression of immediate recurrences of atrial fibrillation after transthoracic cardioversion.

Journal of cardiovascular pharmacology and therapeutics 20020701

The JT-area indicates dispersion of repolarization in dogs with atrioventricular block.

Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing 20020601

Effects of verapamil and ibutilide on atrial fibrillation and postfibrillation atrial refractoriness.

Journal of cardiovascular electrophysiology 20020201

New antiarrhythmic drugs for the treatment of atrial fibrillation.

Pacing and clinical electrophysiology : PACE 20020201

Clinical and electrophysiologic effects of calcium channel blockers in patients receiving ibutilide.

American heart journal 20020101

Ibutilide in rapid conversion of atrial flutter in octogenarians.

Drugs & aging 20020101

Ibutilide-induced long QT syndrome and torsade de pointes.

American journal of therapeutics 20020101

Electrophysiological effects of ibutilide in patients with accessory pathways.

Circulation 20011016

[Severe ibutilide-induced arrhythmia in patients with heart failure].

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 20011010

Cardiovascular effects of the R- and S-enantiomers of ibutilide in conscious beagle dogs.

Methods and findings in experimental and clinical pharmacology 20011001

Ibutilide induced intraatrial Wenckebach periodicity in the neonatal canine heart.

Pacing and clinical electrophysiology : PACE 20010901

Ibutilide: efficacy and safety in atrial fibrillation and atrial flutter in a general cardiology practice.

Clinical cardiology 20010701

Female gender does not influence the magnitude of ibutilide-induced repolarization delay and incidence of torsades de pointes in an in vivo rabbit model of the acquired long QT syndrome.

Journal of cardiovascular pharmacology and therapeutics 20010701

Comparison of the rate dependent effects of dofetilide and ibutilide in the newborn heart.

Pacing and clinical electrophysiology : PACE 20010501

Safety and effectiveness of ibutilide in a community hospital.

Pharmacotherapy 20010401

Progress toward the development of a safe and effective agent for treating reentrant cardiac arrhythmias: synthesis and evaluation of ibutilide analogues with enhanced metabolic stability and diminished proarrhythmic potential.

Journal of medicinal chemistry 20010329

Usefulness of handgrip to improve ibutilide efficacy in organizing atrial electrical activity during atrial fibrillation.

The American journal of cardiology 20010315

Drug-induced QT prolongation in women during the menstrual cycle.

JAMA 20010314

Frequency-dependent electrophysiological effect of ibutilide on human atrium and ventricle.

Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing 20010301

Comparison of the effects on drug concentrations, electrophysiologic parameters, and termination of atrial fibrillation in dogs when procainamide and ibutilide are delivered into the right atrium versus intravenously.

Journal of cardiovascular electrophysiology 20010301

Myocardial repolarization and drugs. Impossibility to predict the dominance of anti-arrhythmic over pro-arrhythmic effects of drugs due to differential and ventricular electrical remodeling.

Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology 20010301

Potassium and calcium current blocking properties of the novel antiarrhythmic agent H 345/52: implications for proarrhythmic potential.

Cardiovascular research 20010201

Chemical cardioversion of atrial fibrillation or flutter with ibutilide in patients receiving amiodarone therapy.

Circulation 20010116

Altered response to ibutilide in a heart failure model.

Cardiovascular research 20010101

Ibutilide: a class III rapidly acting antidysrhythmic for atrial fibrillation or atrial flutter.

The Journal of emergency medicine 20010101

Multifocal atrial tachycardia and Ibutilide.

The American journal of geriatric cardiology 20010101

Newer antiarrhythmic drugs.

Indian heart journal 20010101

New antiarrhythmic agents for atrial fibrillation.

Current opinion in investigational drugs (London, England : 2000) 20010101

Pharmacologic conversion of atrial fibrillation: a systematic review of available evidence.

Progress in cardiovascular diseases 20010101

Termination of recent-onset atrial fibrillation/flutter in the emergency department: a sequential approach with intravenous ibutilide and external electrical cardioversion.

Resuscitation 20000801

Usefulness of ibutilide in facilitating successful external cardioversion of refractory atrial fibrillation.

The American journal of cardiology 19991101

Acute renal failure after ibutilide.

Lancet (London, England) 19990206